Table 3.
Univariate and multivariate analysis of prognostic factors for disease-free survival (n = 118)
| Characteristics | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p value | OR | 95% CI | p value | |
| Age, years | ||||||
| <60 | 1 (Ref) | - | - | |||
| ≥60 | 1.392 | 0.762-2.543 | 0.282 | |||
| FIGO stage | ||||||
| I | 1 (Ref) | - | - | 1 (Ref) | - | - |
| II-IV | 2.976 | 1.682-5.268 | < 0.001* | 2.420 | 1.357 - 4.319 | 0.003* |
| LVSI | ||||||
| No | 1 (Ref) | - | - | 1 (Ref) | - | - |
| Yes | 2.345 | 1.344-4.091 | 0.003* | 1.826 | 0.773 - 4.963 | 0.171 |
| LN metastasis | ||||||
| No | 1 (Ref) | - | - | 1 (Ref) | - | - |
| Yes | 2.717 | 1.563-4.723 | < 0.001* | 1.030 | 0.419 - 2.534 | 0.948 |
| NLR | ||||||
| < 1.316 | 1 (Ref) | - | - | 1 (Ref) | - | - |
| ≥ 1.316 | 3.670 | 1.457-9.247 | 0.006* | 1.797 | 0.680 - 4.751 | 0.237 |
| PLR | ||||||
| < 132.4 | 1 (Ref) | - | - | 1 (Ref) | - | - |
| ≥ 132.4 | 2.408 | 1.354-4.283 | 0.003* | 1.555 | 0.853 - 2.837 | 0.150 |
| MLR | ||||||
| < 0.191 | 1 (Ref) | - | - | 1 (Ref) | - | - |
| ≥ 0.191 | 5.245 | 2.359-11.665 | < 0.001* | 3.647 | 1.600 - 8.315 | 0.002* |
Covariates with p < 0.05 on univariate analysis were included in multivariate model.OR, odds ratio; CI, confidence interval; Ref, reference; FIGO, International Federation of Gynecology and Obstetrics; LVSI, lymphovascular space invasion; LN, lymph node; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio.